Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Rose 91.3% in First Half of 2023

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 135.7 million yuan in the first half of 2023, up 91.3% year-on-year.

Meanwhile, the company posted 3.2 billion yuan in revenue, up 18.7% year-on-year.

At the end of the reporting period, it had 8.3 billion yuan in total assets and 4.7 billion yuan in total liabilities, with a liability-to-asset ratio of 56.2%.